Ophthalmic Prostaglandin Agonists

Ophthalmic prostaglandin agonists, commonly referred to as ophthalmic prostaglandin analogues or FP-receptor agonists, are a therapeutic class of topical ocular hypotensive agents

Ophthalmic prostaglandin agonists, commonly referred to as ophthalmic prostaglandin analogues or FP-receptor agonists, are a therapeutic class of topical ocular hypotensive agents They function primarily by stimulating prostaglandin receptors in the eye to enhance uveoscleral and trabecular outflow of aqueous humor, thereby significantly reducing intraocular pressure

They function primarily by stimulating prostaglandin receptors in the eye to enhance uveoscleral and trabecular outflow of aqueous humor, thereby significantly reducing intraocular pressure

Members of this class, including latanoprost, bimatoprost, travoprost, and tafluprost, serve as first-line pharmacotherapies for the management of open-angle glaucoma and ocular hypertension